Satisfaction associated with gender-affirming hormone therapy.

Area of Science:

• Endocrinology
• Psychiatry
• Sociology

Background:

• Gender Affirming Hormone Therapy (GAHT) is known to improve psychological well-being and quality of life.
• However, patient satisfaction with GAHT remains an under-researched area.
• This study aimed to quantify satisfaction levels among transgender individuals undergoing GAHT.

Purpose of the Study:

• To assess patient satisfaction with Gender Affirming Hormone Therapy (GAHT).
• To evaluate the impact of GAHT on emotional well-being and problem resolution.
• To identify factors influencing satisfaction with GAHT.

Main Methods:

• A cross-sectional observational study was conducted with 83 transgender individuals receiving GAHT for over one year.
• Participants were recruited from a Transgender Medicine Unit.
• Patient satisfaction was measured using the Spanish adaptation of the received treatment satisfaction scale (CRES-4), alongside demographic and clinical data collection.

Main Results:

• 95% of participants reported satisfaction with GAHT, and 75% experienced improved problem resolution.
• Emotional well-being significantly improved, with 68% reporting an acceptable emotional state post-GAHT compared to 9% pre-treatment.
• Satisfaction levels were not significantly correlated with treatment duration, age at initiation, comorbidities, or type of surgery.

Conclusions:

• The majority of transgender individuals express high satisfaction with GAHT when integrated into comprehensive care.
• GAHT effectively enhances emotional well-being and perceived problem resolution.
• These findings underscore the importance of GAHT in improving the quality of life for transgender individuals.